X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6055) 6055
Publication (499) 499
Newsletter (429) 429
Newspaper Article (72) 72
Book Review (61) 61
Magazine Article (28) 28
Book Chapter (19) 19
Web Resource (6) 6
Conference Proceeding (3) 3
Dissertation (3) 3
Transcript (2) 2
Book / eBook (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4810) 4810
hydroxyurea (3555) 3555
hydroxyurea - therapeutic use (2668) 2668
female (2483) 2483
male (2446) 2446
adult (1814) 1814
hematology (1683) 1683
index medicus (1660) 1660
middle aged (1610) 1610
aged (1146) 1146
oncology (1126) 1126
hydroxyurea - administration & dosage (928) 928
sickle cell anemia (897) 897
hydroxyurea - adverse effects (854) 854
adolescent (803) 803
anemia, sickle cell - drug therapy (755) 755
therapy (736) 736
child (735) 735
anemia (727) 727
hydroxyurea - pharmacology (673) 673
treatment outcome (631) 631
animals (629) 629
sickle cell disease (613) 613
antineoplastic agents - therapeutic use (570) 570
children (554) 554
care and treatment (553) 553
research (552) 552
disease (507) 507
antisickling agents - therapeutic use (460) 460
antineoplastic combined chemotherapy protocols - therapeutic use (443) 443
cancer (442) 442
medicine, general & internal (412) 412
child, preschool (410) 410
drug therapy, combination (397) 397
drug therapy (377) 377
pediatrics (376) 376
hemoglobin (370) 370
essential thrombocythemia (369) 369
anemia, sickle cell - complications (367) 367
combined modality therapy (367) 367
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (356) 356
chemotherapy (354) 354
polycythemia-vera (336) 336
follow-up studies (328) 328
aged, 80 and over (324) 324
mice (324) 324
anemia, sickle cell - therapy (322) 322
anemia, sickle cell - blood (319) 319
risk factors (316) 316
pharmacology & pharmacy (313) 313
time factors (309) 309
interferon-alpha - therapeutic use (307) 307
retrospective studies (303) 303
prognosis (298) 298
health aspects (293) 293
young adult (287) 287
chronic myelogenous leukemia (282) 282
thrombocythemia, essential - drug therapy (280) 280
medical research (268) 268
article (256) 256
analysis (255) 255
polycythemia vera - drug therapy (255) 255
antineoplastic agents - adverse effects (250) 250
risk-factors (244) 244
blood transfusion (243) 243
leukemia (243) 243
hydroxyurea - analogs & derivatives (235) 235
mutation (228) 228
dose-response relationship, drug (223) 223
survival (222) 222
medicine & public health (220) 220
medicine, experimental (220) 220
drugs (213) 213
myeloproliferative disorders (209) 209
reports (207) 207
radiotherapy (205) 205
clinical trials as topic (203) 203
polycythemia vera (203) 203
trial (203) 203
hemic and lymphatic diseases (199) 199
leukemia, myelogenous, chronic, bcr-abl positive - therapy (196) 196
management (196) 196
diagnosis (194) 194
risk (192) 192
thalassemia (192) 192
fetal hemoglobin (191) 191
patients (188) 188
drug administration schedule (186) 186
hiv infections - drug therapy (185) 185
immunology (185) 185
expression (183) 183
antineoplastic agents - administration & dosage (182) 182
hydroxyurea therapy (178) 178
infant (175) 175
medicine (175) 175
anemia, sickle cell - physiopathology (173) 173
fetal-hemoglobin (173) 173
imatinib mesylate (173) 173
prospective studies (172) 172
survival analysis (172) 172
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6114) 6114
French (146) 146
German (116) 116
Japanese (54) 54
Spanish (45) 45
Polish (31) 31
Russian (28) 28
Italian (20) 20
Chinese (13) 13
Hungarian (11) 11
Korean (8) 8
Dutch (5) 5
Portuguese (4) 4
Hebrew (3) 3
Swedish (3) 3
Czech (2) 2
Danish (2) 2
Norwegian (2) 2
Slovak (2) 2
Turkish (2) 2
Arabic (1) 1
Croatian (1) 1
Finnish (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 426 - 435
Journal Article
Study - Hydroxyurea as an alternative therapy for psoriasis, 01/2004
Methotrexate is the drug of choice in extensive psoriasis in developing countries. In patients who can not take methotrexate either due to intolerance or... 
Dermatology | Psoriasis, Hydroxyurea, PASI. dv04003
Journal
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2018 - 2031
Summary Sickle-cell disease is one of the most common severe monogenic disorders in the world. Haemoglobin polymerisation, leading to erythrocyte rigidity and... 
Internal Medicine | FETAL-HEMOGLOBIN LEVELS | MEDICINE, GENERAL & INTERNAL | HOSPITAL ADMISSIONS | RISK-FACTORS | PULMONARY-HYPERTENSION | ACUTE CHEST SYNDROME | HYDROXYUREA THERAPY | NITRIC-OXIDE | ADHESION MOLECULES | ACUTE VASOOCCLUSIVE CRISIS | PLASMODIUM-FALCIPARUM MALARIA | Haplotypes | Antisickling Agents - therapeutic use | Acute Chest Syndrome - etiology | Acute Chest Syndrome - therapy | Humans | Pain Management | Hypertension, Pulmonary - therapy | Blood Transfusion | Anemia, Sickle Cell - epidemiology | Erythrocytes - pathology | Pain - etiology | Anemia, Sickle Cell - classification | Hemolysis | Severity of Illness Index | Gene Transfer Techniques | Iron Chelating Agents - therapeutic use | Disease Susceptibility | Anemia, Sickle Cell - complications | Africa | Hematopoietic Stem Cell Transplantation | Polymerization | Nervous System Diseases - therapy | Anemia, Sickle Cell - therapy | Heart Diseases - etiology | Mass Screening | Heart Diseases - therapy | Kidney Diseases - therapy | Nervous System Diseases - etiology | Hydroxyurea - therapeutic use | Anemia, Sickle Cell - blood | Anemia, Sickle Cell - diagnosis | Kidney Diseases - etiology | Hypertension, Pulmonary - etiology | Hematopoietic Stem Cells | Care and treatment | Sickle cell anemia | Hemoglobin | Development and progression | Diagnosis | Health aspects | Risk factors | Disease | Rodents | Nitric oxide | Mutation | Gene therapy | Epidemiology | Federal funding
Journal Article
Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 11/2018, Volume 2018, Issue 1, pp. 361 - 370
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. 2514 - 2520
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 08/2017, Volume 318, Issue 7, pp. 604 - 604
After nearly 20 years without new treatments for sickle cell disease, the FDA has approved L-glutamine oral powder to reduce severe complications of the blood... 
MEDICINE, GENERAL & INTERNAL | Complications | Medical treatment | Blood cells | Erythrocytes | Blood vessels | Amino acids | Hydroxyurea | FDA approval | Blood | Powder | Endothelial cells | Pain | Red blood cells | Sickle cell disease | Drought | Glutamine
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 24, pp. 2585 - 2591
Journal Article